GSRX Industries Inc.

GSRX

US36255V1070

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:31:07 2024-03-25 am EDT			5-day change	1st Jan Change
0.0002 ^USD	-.--%		-.--%	-.--%

2021	Gsrx Industries Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI
2021	GSRX Industries Inc. Announces Resignation of Aman Parmar as Member of the Board of Directors	CI

Gsrx Industries Inc. Appoints Steven Farkas to Serve as A Director of the Corporation

May 12, 2020 at 03:37 pm EDT

GSRX Industries Inc. approved the appointment of Mr. Steven Farkas to serve as a director of the Corporation, such appointment to be effective January 21, 2020.

Latest news about GSRX Industries Inc.

Gsrx Industries Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	21-02-16	CI
GSRX Industries Inc. Announces Resignation of Aman Parmar as Member of the Board of Directors	21-01-08	CI
Department of Health of Puerto Rico Has Not Renewed Licenses Held by GSRX Industries Inc	20-11-04	CI
Seneca Capital Partners, LP acquired 95% interest in Green Room Palm Springs, LLC from GSRX Industries Inc. for $0.4 million.	20-10-18	CI
Gsrx Industries Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-11	CI
GSRX Industries Inc. Auditor Raises 'Going Concern' Doubt	20-06-10	CI
Gsrx Industries Inc. Appoints Steven Farkas to Serve as A Director of the Corporation	20-05-12	CI
GSRX Industries Inc. Announces Resignation of Mike Aujla as Member of the Board of Directors	20-05-08	CI
GSRX Industries Inc. Announces Board Changes	20-05-06	CI
GSRX Industries Inc. Announces Management Changes	20-03-11	CI
Gsrx Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-19	CI
GSRX Industries Inc Announces Resignation of Andrew Alvis as Chief Operating Officer	19-10-03	CI
GSRX Industries Inc. Receives State-Wide Manufacturing and Distribution Licenses for its Facility in Point Arena, California	19-09-23	CI
Cyberspace Vita, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-09-20	CI
GSRX Industries Inc. Appoints Aman Parmar as Director	19-09-18	CI
GSRX Industries Inc. Announces Board Changes	19-08-29	CI
Chemesis International Inc. completed the acquisition of 72.96% stake in GSRX Industries Inc. from Peach Management LLC, Dorado Consulting, LLC and others for $12.1 million.	19-08-28	CI
Chemesis International Inc. Provides Update on Operations and GSRX Transaction	19-08-23	CI
Chemesis International Inc. entered into binding share exchange agreement to acquire 72.96% stake in GSRX Industries Inc. from Peach Management LLC, Dorado Consulting, LLC and others for $18.6 million.	19-08-04	CI
GSRX Industries Inc. Retains Studio AR&D Architects and Leap Interiors for Design of New the Green Room California Adult-Use and Medicinal Cannabis Dispensary in Palm Springs	19-07-26	CI
Gsrx Industries Appoints Andrew Alvis Chief Operating Officer	19-07-17	CI
GSRX Industries Inc. Launches Zen Stop in Los Angeles	19-07-16	CI
GSRX Industries Inc. Announces Revenue Results for the Second Quarter of 2019	19-07-16	CI
Zen Stop announced that it has received funding from GSRX Industries Inc.	19-07-15	CI
Gsrx Industries Inc. Expecting Strong Sales for Second Quarter of 2019	19-04-23	CI

GSRX Industries Inc, through its subsidiaries, is in the business of acquiring, developing, and operating retail cannabis dispensaries and non-tetrahydrocannabinol (THC) cannabidiol (CBD) retail stores. The Company also is in the process of expanding its business to include distribution, extraction and light manufacturing, and delivery of cannabis and cannabinoid products. It operates five cannabis dispensaries in Puerto Rico under the name Green Spirit RX and one dispensary in California under the name The Green Room. The Company also owns and operates the e-commerce site GetPureAndNatural.com, which offers a broad range of hemp extract products.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GSRX INDUSTRIES INC.	-.--%	16.36K
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals